AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glipotec M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Jantec Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glipotec M 1mg/500mg Tablet SR

Metformin/Glipizide extended-release tablets (1mg/500mg) are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before using this medication during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests as directed by your physician, is necessary.

Primary Ingredients of Glipotec M 1mg/500mg Tablet SR

No information provided. A rephrased version cannot be created.

Uses of Glipotec M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glipotec M 1mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Glipotec M 1mg/500mg Sustained-Release tablets with food.

Common Side effects of Glipotec M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glipotec M 1mg/500mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glipotec M 1mg/500mg Extended-Release Tablets with food.

How Glipotec M 1mg/500mg Tablet SR works:

Glipotec M SR tablets (1mg/500mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glipotec M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glipotec M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Consult your physician for advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glipotec M (1mg/500mg) tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glipotec M 1mg/500mg SR tablets cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Glipotec M 1mg/500mg SR tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glipotec M 1mg/500mg SR tablets to individuals with hepatic impairment; dosage modifications may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver disease, initiate Glipotec M 1mg/500mg SR tablets at a reduced dosage; however, its administration is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glipotec M 1mg/500mg Tablet SR :

Should you forget a dose of your Glipotec M 1mg/500mg SR tablet, take it immediately. If, however, your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glipotec M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glipotec M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glipotec M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glipotec M and seek immediate medical attention.
Glipotec M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glipotec M 1mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glipotec M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glipotec M 1mg/500mg SR Tablets can induce hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glipotec M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glipotec M 1mg/500mg Tabl...
42
MRP 49
13% off